Sequence information
Variant position: 164 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 767 The length of the canonical sequence.
Location on the sequence:
LQALKESLQMSLSLLPPDAL
V GLITFGRMVQVHELSCEGIS
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human LQALKESLQMSLSLLPPDALV GLITFGRMVQVHELSCEGIS
Mouse LQALKESLQMSLSLLPPDALV GLITFGRMVQVHELSCEGIS
Bovine LQALKESLQMSLSLLPPDALV GLITFGRMVQVHELSCEGIS
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
2 – 767
Protein transport protein Sec23B
Literature citations
Germline heterozygous variants in SEC23B are associated with Cowden syndrome and enriched in apparently sporadic thyroid cancer.
Yehia L.; Niazi F.; Ni Y.; Ngeow J.; Sankunny M.; Liu Z.; Wei W.; Mester J.L.; Keri R.A.; Zhang B.; Eng C.;
Am. J. Hum. Genet. 97:661-676(2015)
Cited for: VARIANTS CWS7 LEU-164 AND GLY-594; CHARACTERIZATION OF VARIANT CWS7 GLY-594; INTERACTION WITH SAR1A; SUBCELLULAR LOCATION;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.